No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19. Data of 397 adult patients with severe COVID-19 admitted to a designated clinical center of Wuhan Union...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
De Gruyter
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5417170dbca341d691b37fd4420b6f22 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|